American Equities Overseas
1
25M
1
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the American Equities Overseas, startups are often financed by Saratoga Ventures, Nexus Medical Partners, DeNovo Ventures. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, Saratoga Ventures, Medicis Capital. In the next rounds fund is usually obtained by Valiance Asset Management, Accuitive Medical Ventures.
Among the various public portfolio startups of the fund, we may underline MyoScience Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2013. The typical startup value when the investment from American Equities Overseas is 100-500 millions dollars.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Therapeutics (1)
- Pharmaceutical (1)
- Biotechnology (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 130M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.